Receptor-mediated signalings-regulating proliferation, differentiation and neoplastic transformation of hematopoietic cells

受体介导的信号传导——调节造血细胞的增殖、分化和肿瘤转化

基本信息

  • 批准号:
    09470231
  • 负责人:
  • 金额:
    $ 9.09万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1997
  • 资助国家:
    日本
  • 起止时间:
    1997 至 1999
  • 项目状态:
    已结题

项目摘要

The c-kit receptor tyrosine kinase (KIT) and its ligand, stem cell factor (SCF) transduce crucial signals in hematopoietic cells. We revealed that two point mutations, Val559→Gly (G559) mutation in the juxtamembrane domain and Asp814→Val (V814) mutation in the kinase domain, lead to constitutive and oncogenic activation of KIT. In order to determine as to which portion of mutant KITs is indispensable for receptor dimerization or self-association in the absence of SCF, we have constructed a series of deletion and chimeric mutants of KIT, including the extracellular domain truncated type KIT and chimeric type KIT in which extracellular and transmembrane domains are replaced by src myristylation signal peptide. By using murine interleukin (IL)-3-dependent Ba/F3 cells that were subjected to transfection of various c-kit genes, we showed that the constituvely activating mutations at both the juxtamembrane and kinase domains of KIT may not necessarily require their extracellular and transmem … More brane domains for their formation of receptor self-association, and that the receptor self-association of mutant KIT may be important for activation of downstream effectors that are required for factor-independent growth and tumorigenicity.In addition to the SCF/KIT system, thrombopoietin (TPO)/c-mpl system also plays a fundamental role in hematopoiesis. In an effort to clarify the mechanisms of TPO-induced proliferation and differentiation, c-mpl was introduced into human IL-3-dependent F-36P cells. F-36P-mpl cells were found to proliferate and differentiate at a high rate into mature megakaryocytes in response to TPO. By using dominant-negative (dn) forms of STATs and ras, it was suggested that TPO-induced proliferation may be mediated through activation of STAT5 and ras, and that prolonged ras activation may be involved in TPO-induced megakaryocytic differentiation. Furthermore, we found that STAT5, in addition to ras signaling, appeared to mediate transcriptional regulation of cyclin D1 during cytokine-dependent growth in hematopoietic cells. Less
C-KIT受体酪氨酸激酶(试剂盒)及其配体干细胞因子(SCF)在造血细胞中的透射信号,Val559→Gly(G559)突变(G559)突变激酶结构域中的突变,导致试剂盒的构成性和致癌性激活,以用于受体二聚体或自我关联,在没有SCF的情况下,我们已经构建了一系列的删除和嵌合物突变体在其中使用鼠白介素(IL)-3-二足体BA/F3细胞替代了细胞外和跨膜INS的试剂盒。试剂盒的近去膜和激酶结构域可能不会不需要割让,需要其细胞外和传输……更多的Brene域才能形成受体自我结合,而Mutt套件的受体自我遵循对于激活下游效应物的受体自我遵循的能力很重要在SCF/KIT系统中,非因子独立和肿瘤型,血小板蛋白(TPO)/C-MPL系统在造血中也起着基本作用。被引入人IL-3多种F-36p细胞中。通过STAT5和RAS的激活,延长的RAS激活可能与TPO诱导的巨核细胞分化有关。较少的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nishida,T., et al.: "Familial gastrointestinal stromal tumors with germ line mutation of the KIT gene." Nature Genet.19. 323-324 (1998)
Nishida,T., et al.:“具有 KIT 基因种系突变的家族性胃肠道间质瘤。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tsujimura, T. , et al.: "Consitutively activating mutation in the catalytic domain of c-kit elicits hematopoietic transformation by receptor self-association not at the ligand-dependent dimerization site"Blood. 93. 1319-1329 (1999)
Tsujimura, T. 等人:“c-kit 催化结构域中的组成性激活突变可通过受体自缔合而不是在配体依赖性二聚化位点引发造血转化”Blood。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Daino, H., et al.: "Induction blocks apoprosis by extracellular ubiquitin in human hematopoietic cells: possible involvement of Stat3 degradation by proteasome pathway in interleukin 6-dependent"Blood. 95(in press). (2000)
Daino, H., 等人:“人类造血细胞中细胞外泛素诱导阻断细胞凋亡:白细胞介素 6 依赖性蛋白酶体途径可能参与 Stat3 降解”血液。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tsujimura, T., et al.: "Constitutively activating mutation in the catalytic domain of c-kit receptor tyrosine kinase elicits hematopoietic transformation by receptor self-asociation not at the ligand-dependent dimerization site"Blood. 93. 1319-1329 (1999)
Tsujimura, T. 等人:“c-kit 受体酪氨酸激酶催化结构域中的组成性激活突变可通过受体自身缔合而不是在配体依赖性二聚化位点引发造血转化”血液。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Matsumura,I., et al.: "Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line." Mol.Cell.Biol.18. 4282-4290 (1998)
Matsumura,I. 等人:“ras 延长激活参与血小板生成素诱导的人类因子依赖性造血细胞系的巨核细胞分化。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KANAKURA Yuzuru其他文献

KANAKURA Yuzuru的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KANAKURA Yuzuru', 18)}}的其他基金

Functional analysis of SATB1, a global transcription regulator, in hematopoietic stem cells
造血干细胞中全局转录调节因子 SATB1 的功能分析
  • 批准号:
    16H05339
  • 财政年份:
    2016
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of the functions of anti-apoptotic molecule, Anamorsin -the roles in hematopoiesis and cellular iron metabolism-
抗凋亡分子Anamorsin的功能分析-在造血和细胞铁代谢中的作用-
  • 批准号:
    25293220
  • 财政年份:
    2013
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Screening of low molecular compounds, which inhibit cell proliferation and survival
筛选抑制细胞增殖和存活的低分子化合物
  • 批准号:
    23659488
  • 财政年份:
    2011
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Analysis of functions of anamorsin, an anti-apoptotic molecule, in hematopoiesis
抗凋亡分子阿莫辛的造血功能分析
  • 批准号:
    22390194
  • 财政年份:
    2010
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Synthetic Analysis on the mechanisms of survival and differentiation of hematopoietic cells
造血细胞存活和分化机制的综合分析
  • 批准号:
    18209034
  • 财政年份:
    2006
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Analysis of molecular mechanisms of leukemia
白血病分子机制分析
  • 批准号:
    17016042
  • 财政年份:
    2005
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Analysis on the mechanisms of growth, differentiation, and survival of megakaryocytic cells
巨核细胞生长、分化和存活机制分析
  • 批准号:
    16209033
  • 财政年份:
    2004
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Analysis on the mechanism of survival, growth and differentiation of hematopoietic cells
造血细胞存活、生长和分化机制分析
  • 批准号:
    14370302
  • 财政年份:
    2002
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular mechanisms regulating the growth and differentiation of hematopoietic stem cells
调节造血干细胞生长和分化的分子机制
  • 批准号:
    12470200
  • 财政年份:
    2000
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似国自然基金

地榆单体MOG通过非TPO/c-MPL依赖的lncMKD/HIF-1β/NF-E2通路促进巨核细胞分化的机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
IFN-γ-STAT1-SOCS-1下调促血小板生成素受体c-MPL在重型再生障碍性贫血发病中的机制研究
  • 批准号:
    82070127
  • 批准年份:
    2020
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
ITP患者巨核细胞中通过抑制JIP3表达调节c-Mpl在细胞膜表面的分布及其机制研究
  • 批准号:
    81873425
  • 批准年份:
    2018
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目
双重靶标c-Mpl和STAT3/5拮抗多肽的筛选及其对白血病细胞的动态调控
  • 批准号:
    31771273
  • 批准年份:
    2017
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目

相似海外基金

A Novel Bone Marrow Transplantation Approach for Sickle Cell Disease Using Targeted Marrow Irradiation
使用靶向骨髓照射治疗镰状细胞病的新型骨髓移植方法
  • 批准号:
    10737358
  • 财政年份:
    2023
  • 资助金额:
    $ 9.09万
  • 项目类别:
The pathophysiology of type 1 versus type 2 mutant calreticulin-drivenmyeloproliferative neoplasms
1 型与 2 型突变钙网蛋白驱动的骨髓增殖性肿瘤的病理生理学
  • 批准号:
    10503876
  • 财政年份:
    2022
  • 资助金额:
    $ 9.09万
  • 项目类别:
Targeted non-genotoxic hematopoietic stem cell transplant conditioning approach
靶向非基因毒性造血干细胞移植调理方法
  • 批准号:
    10242836
  • 财政年份:
    2019
  • 资助金额:
    $ 9.09万
  • 项目类别:
Targeted non-genotoxic hematopoietic stem cell transplant conditioning approach
靶向非基因毒性造血干细胞移植调理方法
  • 批准号:
    10475199
  • 财政年份:
    2019
  • 资助金额:
    $ 9.09万
  • 项目类别:
Targeted non-genotoxic hematopoietic stem cell transplant conditioning approach
靶向非基因毒性造血干细胞移植调理方法
  • 批准号:
    10674774
  • 财政年份:
    2019
  • 资助金额:
    $ 9.09万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了